Podcasts about imq

Jon Mendiguren, trabajador de IMQ y responsable de la coordinación del despliegue de sanitarios en los partidos, cuenta en Radio Euskadi la atención que tuvo que recibir un aficionado en la grada....

Link to bioRxiv paper: http://biorxiv.org/cgi/content/short/2023.01.06.523014v1?rss=1 Authors: Liu, T., Wang, H., Kutsovsky, D. Y., Ohn, C. Y., Patel, N., Yang, J., Simon, D. J. Abstract: Inflammation is closely associated with many neurodegenerative disorders. Yet whether inflammation causes or exacerbates neurodegeneration has been challenging to define because the two processes are so closely linked. Here we disentangle inflammation from the axon damage it causes by individually blocking cytotoxic T cell function and axon degeneration. We model inflammatory damage in mouse skin, a barrier tissue that, despite frequent inflammation, must maintain proper functioning of a dense array of axon terminals. We show that sympathetic axons control skin inflammation through release of norepinephrine, which suppresses activation of gamma delta T cells via the beta2 adrenergic receptor. Strong inflammatory stimulation in the form of the toll like receptor 7 (TLR7) agonist imiquimod (IMQ) causes progressive gamma delta T cell-mediated, Sarm-1-dependent loss of these immunosuppressive sympathetic axons, a positive feedback loop that removes a physiological brake on T cells, resulting in enhanced inflammation and inflammatory axon damage. Copy rights belong to original authors. Visit the link for more info Podcast created by Paper Player, LLC

Las reacciones de diferentes estamentos ante el anunció ayer por parte del presidente del Gobierno de ayudas a la funcionalidad de las empresas en la provincia de Soria .El ayuntamiento de Soria congelará el IBI el próximo año e incrementa las bonoficaciones.La nueva presidenta de la Confederación del Duero, la soriana Mª Jesús Lafuente Molinero aboga por el diálogo con los municipios.El Ministerio de Transportes formaliza el contrato para realizar el estudio de viabilidad del corredor ferroviario Soria-Castejón.La policía detiene a dos personas que tenía una plantación de marihuana en su piso.El Numancia buscará este fin de semana en Calahorra su cuarta victoria consecutiva. _El Río Duero de voleibol recibe al campeón de liga, Unicaja Almería; y el Balonmano Soria busca revertir sus malos resultados ante IMQ.   Escuchar audio

Join us as Pastor Jason continues our Summer Series with a message about being obedient to God and use your talents to bless other people, you will be more fulfilled. If you want to receive prayer, give, or get connected with HighPoint in any way, text HPINFO to 97000. To watch the entire service including introductions and announcements, go to: https://youtu.be/BaG_9wv-iMQ

Le prime pagine dei principali quotidiani nazionali commentate in rassegna stampa da Davide Giacalone. Dopo le elezioni i primi scossoni nel governo, Draghi prepara il viaggio a Kiev. Per #ilpostinfabbrica, IMQ oggi la più importante azienda italiana di valutazione di conformità. Ha 1.300 persone in staff e ne cerca subito almeno 50. In diretta con noi Maurizio Sacchi, HR Director di IMQ. Don Antonio Mazzi, fondatore della comunità Exodus, regala ogni giorno un pensiero, un suggerimento, una frase agli ascoltatori di RTL 102.5. Martina Patti, 23 anni, ha confessato di aver ucciso la sua bambina Elena, di 5 anni. Del caso abbiamo parlato, in diretta, con Roberta Bruzzone, criminologa. 13,30 di oggi partirà la quarantesima edizione della riedizione della storica Mille Miglia. Ce l'ha raccontata Beatrice Saottini, per 9 edizioni ha gareggiato da concorrente ma oggi è presidente di quella che Enzo Ferrari definì "La corsa più bella del mondo". In Non Stop News ancora uno spazio dedicato alla più stretta attualità. Dall'aumento dei tassi di interesse della BCE alla risalita dello spread. In diretta con noi il direttore di Milano Finanza, Roberto Sommella. Non Stop News, con Giusi Legrenzi, Enrico Galletti e Massimo Lo Nigro.

In this New Year's Eve themed season finale, JL and Nikki B play some fun New Year's games, present a new IMQ, and feature funny segments. JL will give his point-of-view in his address, and Taylor-Taylor will bring you entertainment news.

In this holiday themed episode nine, JL and Nikki B play some fun Christmas games, present a new IMQ, and feature funny segments. JL will give his point-of-view in his address, and Taylor-Taylor will bring you entertainment news.

In episode eight, JL and Nikki B discuss current topics, present a new IMQ, and feature funny segments. JL will give his point-of-view in his address, and Taylor-Taylor will bring you entertainment news.

In episode seven, JL and Nikki B discuss current topics, present a new IMQ, and feature funny segments. JL will give his point-of-view in his address, and Taylor-Taylor will bring you entertainment news.

In episode six, JL and Nikki B discuss current topics, present a new IMQ, and feature funny segments. JL will give his point-of-view in his address, and Taylor-Taylor will bring you entertainment news.

In episode five, JL, Nikki B, and Taylor-Taylor play some "Thanksgiving games", present a new IMQ, and feature funny segments. JL will give his point-of-view in his address, and Taylor-Taylor will bring you entertainment news.

In episode four, JL and Nikki B discuss current topics, present a new IMQ, and feature funny segments. JL will give his point-of-view in his address, and Taylor-Taylor will bring you entertainment news.

In episode three, JL and Nikki B discuss current topics, present a new IMQ, and feature funny segments. JL will give his point-of-view in his address, and Taylor-Taylor will bring you entertainment news.

In episode two, JL and Nikki B discuss current topics, present a new IMQ, and feature funny segments. JL will give his point-of-view in his address, and Taylor-Taylor will bring you entertainment news.

Is The U.S. Healthcare System Failing Due to Greed, Ignorance, or Arrogance? Featuring Dr. Robert Yoho What's wrong with America's healthcare system? We are the richest most developed country in the world and we refuse to take care of our own. Even if you have decent insurance you have to fight for everything you get. Forget about those uninsured for whatever reason. We can and should be committed to doing much better. Let's start demanding more. Now!!! About Dr. Robert I was born in l953 in Richmond, Virginia, and grew up in Kent, Ohio, (known for the Kent State riots during the Vietnam war), was an Eagle Scout, and a Judo wrestler. I spent four years at Oberlin College and went to Small College National Championships in Varsity Wrestling my senior year. Then, was accepted at one of the finest medical schools in the United States, Case Western Reserve University in Cleveland, Ohio. At 22 years old, one year into my medical education, I decided that I needed to “find myself” and took a two-year sabbatical. After starting and managing a tree surgery business, I went to Wyoming to work on oil drilling rigs, and then spent the next year traveling to rock climbing areas. I became a master climber and traveled to cliffs in twelve states. Additionally, I published articles in climbing magazines and made “first ascents” at Devil's Tower, Wyoming, and Joshua Tree, California. I made an early ascent of “The Naked Edge,” a classic climb near Denver, and climbed the Long's Peak Diamond. As recently as the mid-1980s, I climbed such difficult classics as Astroman, the west face of El Capitan, and the Crucifix in Yosemite, free climbing up to a mid-“5.12” difficulty level. I climbed the Regular Northwest Face of Half Dome in 18 hours in 2004 and the Nose route on El Capitan in less than 24 hours in 2005. After returning to medical school in l978, I found that bodybuilding complemented my studies. With the added responsibility of specialty training and professional pressures, I had less opportunity for athletics in the past decade. However, I ran 14 triathlons in the late '80s and early '90s and made time for some Kempo Karate (though injuries sidelined me). I have practiced Astanga (flow) Yoga and trained with the legendary 70-year-old master Yogi, Frank White, at the “Center For Yoga” in Hollywood. More recently, I practiced Bikram Yoga and concluded, “it's way hot in there.” (105 to 115 degrees F). I currently practices Baptiste Yoga every day. I married a wonderful woman from Trinidad and had three kids. My son Alan became an All American cross country star in high school, and he and his twin Sarah graduated from Brown University. He now works at Google and Sarah at Nasdaq. Hannah, their older sister, managed a group at the Four Seasons Resorts by the time she was 24. Curriculum Vitae: cosmetic surgery career (now retired) DATE OF BIRTH October 3, 1953 INTERESTS Children, weight lifting, rock climbing, psychology, writing, kayak, Ashtanga and Bikram yoga. Bookworm: Reading averages 3 new books a week. Climbed El Capitan 4 x, Half Dome, Sentinel, Astroman (5.11c), Crucifix (5.12b) in Yosemite. New routes: a grade 5 in Zion and El Matador (5.11) at Devil's Tower, others at Joshua Tree. Climbed regular route on Half Dome in 17 hours 2004. EDUCATION 1971-1975 : Oberlin College Oberlin, Ohio 1975-1981: Case Western Reserve Univ. Medical School 10900 Euclid Ave, Cleveland, Ohio. 44106-4920 POSTGRADUATE TRAINING 1981 – 1982: Internal Medicine Internship R 1 year University of Cincinnati, Cincinnati, OH 1982 – 1983: Dermatology Residency R 2 years Hanover, New Hampshire at Dartmouth-Hitchcock Medical Center One Medical Center Drive, Lebanon, New Hampshire 1983 – 1985: Emergency Medicine Residency Training Los Angeles County Hospital LAC/USC Medical Center 1200 N. State St. Room 1011, Los Angeles, CA Huntington Memorial Hospital, Pasadena, CA WORK HISTORY 2020-2021 full-time writer. 2019: retired from my medical and surgical practice and resigned my medical license. I had a fantastic career, and I was initially sad to end it. But I was soon relieved that I was no longer responsible for patient care and was able to write full time without conflicts of interest. See also the first chapter of Butchered by Healthcare for the circumstances, included on this website under “Writing.” 1992-2019: Cosmetic surgery practice, Pasadena, Visalia, and Oxnard, California. Liposuction, breast implantation specializing in through the umbilicus (belly button), laser blepharoplasty, face-lifts, facial implants, laser resurfacing, vein treatments, hair transplantation. Operated medical hyperbaric chamber between 1996 and 2000. 1987-1994: General practice in Pasadena, California. 1984-1987: Employed by the Huntington Memorial Hospital Emergency Medicine Group, SPECIAL EXPERTISE One of the most extensive experiences in the United States with tumescent liposuction and Brazilian butt lift with fat. Some of our liposuction supply vendors say we are their largest account internationally for several years. Trans-umbilical breast augmentation is a surgery that many try, but few become proficient. Thousands performed. One of only two surgeons in the United States who passed the specialty boards in both cosmetic surgery and emergency medicine. PAST MEMBERSHIPS IN PROFESSIONAL SOCIETIES Los Angeles County Medical Society California Medical Association American Society of Cosmetic Breast Surgery Fellow, American Academy of Cosmetic Surgery ACADEMIC STAFF APPOINTMENTS (INACTIVE) Drew-King Medical Center, assistant clinical professor, Department of Dermatology. Training residents in cosmetic surgery techniques. BOARD CERTIFICATION EXAMINATIONS TAKEN AND PASSED (NOW INACTIVE): American Board of Emergency Medicine (ABEM), 1987. Re-certification examination passed l999 and 2009. 3000 Coolidge Rd., East Lansing, Michigan 48823-6319 American Board of Dermatologic Cosmetic Surgery passed in 1999. Recertification passed ten years later. 18525 Torrence Ave., Lansing Illinois 60438. (708) 474-7200. American Board Laser Surgery passed in 2000. 417 Palmtree Dr. Bradenton, Florida 34210-3009. ACLS re-certification 1999, 2002, 2005. ATLS in past. Member, Fellow, and Past President, American Society of Cosmetic Breast Surgery: testing included written and oral examination as well as peer observation of surgical technique. PEER REVIEW WORK Produced with Robert Goldweber, M.D., Socrates Emergency Medicine Oral Boards Review Course, 1987. This was distributed nationwide for over 5 years. Emergency Medicine Residency Director Huntington Memorial Hospital (coordinated and trained Los Angeles County Hospital emergency medicine residents) 1985-1987. Board of Directors of California Academy of Cosmetic Surgery, 1998-2000. Outpatient surgical facilities reviewer training for IMQ surgical centers and AAAHC surgical centers. (Inactive) Testified before California Medical Board 6/01 regarding liposuction standards and 11/02 regarding expert witness problems. Robert Yoho Website – Hormone Secrets and Butchered by Healthcare www.robertyohoauthor.com www.feedingfatty.com Full Transcript Below Is The U.S. Healthcare System Failing Due to Greed, Ignorance? Featuring Dr. Robert Yoho Wed, 7/21 1:13PM • 1:08:42 SUMMARY KEYWORDS drug, people, doctors, studies, book, good, called, money, influence, fda, problem, patient, alzheimer, industry, patent, hormone, healthcare, crazy, years, standards SPEAKERS Dr. Robert, Terry, Roy Barker   Roy Barker  00:00 One. Hello and welcome to another episode of Feeding Fatty. I'm your host Roy.   Terry  00:08 I'm Terry   Roy Barker  00:08 Of course we are the podcast journaling chronicling our journey through this wellness process. You know, in the beginning, we talked a lot about diet, not a necessarily a diet, but you know what we eat, what, what we're trying to cut down on and be more healthy eating. We also talk a lot about exercise getting out and moving.   And we talk about mindset as well. That has kind of been the point it's led us to a lot of people know what they should be doing, trying to get in the right mindset to make the change, and then also to make it sustainable. That seems to be the difficulty and the challenge for us. But anyway, we also bring guests on from time to time experts in the field today is no different. We are very lucky to have Robert Yoho with us and I'm gonna let Terry introduce him.   Terry  00:55 Now. Robert Yoho is 67 years old. He has spent three decades as a cosmetic surgeon after a career as an emergency physician. His generalist training gives him perspective and allows him to avoid favoring any medical specialty. He's had little deal dealings with hospitals, Big Pharma or insurance companies before he wrote his his book Butchered by Healthcare. No one has ever considered him a whale prescriber or device device implanter he retired from the medical practice in 19. Excuse me, 2019 1999. Dr. Yoho, thank you so much for being on the show. We're so happy to have you as a guest.   Dr. Robert  01:38 Thanks, Terry. Well, let me just go over my sequence which led to my interest in this field. Yeah, I have all things. I did a career in cosmetic surgery, doing breast dog breast implants, liposuction, you know, facial, beautification, all that stuff. And I had two people in six months die in my offices. Oh, wow. And so that was quite a timeframe, introspection, and one of them I wasn't even operating on but it still was a heck of a shock.   And, you know, cosmetic surgeons or plastic surgeons usually have one fatality in surgery during their careers. And I'd had to in a very short sequence, so I started thinking and reading and I started uncovering what I later became started to think of as medical corruption. And so the basic, you know, I'm listening to your guys podcasts. And I see, it's an interesting process, because you have not had chronic diseases, you haven't had to worry about your health, you're, you're pulling your way through this material and thinking you're smelling a rat somewhere, that there's some. And I can tell you, after four years of studying this material, there's a lot wrong. And the bottom line is that we spend twice what the other developed countries spend per person, twice what Japan, Great Britain, France, and so on, and Canada spends per person.   In other words, we spent nearly 20% of our gross domestic product on health care, right? And twice as much per person. And the worst part is we get a bad product, okay? In other words, aren't we have earlier infant mortality. And it's not an academic controversy 50%, fully 50% of what we do, either doesn't work or actually is harmful. And there's many references for that you can look at my book butchered by healthcare to get more detail. But, but it doesn't work. Now, the simple bottom line for how this all developed is we raise money out of the sky, on our health care providers and the healthcare industry.   We gave them our insurance money, we gave them our federal Medicare money. And it was when free money happens, there's a lot of people come around to scoop it up. And these are entrepreneurs, you know, or possibly criminals, you know, that that got into this thing. Now, I'm not saying it's all bad, I don't want to make that message. You know, half of it works, you know, and a half as important and we have new therapies for certain things that are profoundly effective. But and the way these people have influenced our prescribing and the medical devices, and the insurance industry, is essentially through bribery.   Now bribery is a technical term, that term means something in legal jargon, so I really shouldn't use that term, but it's anytime money changes hands, the well is poisoned. And as we You see, you'll see when we go through these various medic medical specialty, there's a lot of money changing hands between industry and the rest of of the medical service providers. I mean, it's a phenomenal thing.   And so the important point, which you can read, if you start looking at influence theory in psychology, is that any amount of money changing hands profoundly affects the person's behavior, even taking a woman out to dinner and serving her a nice meal, you can get benefits that are far beyond the the cost of that meal. You know, that's a simple thing that drug reps come into their offices feed us food. And we think it doesn't influence our behavior, but it does. And it's a terrible thing. So that's the basic setup of medical care worldwide, but particularly in America.   And I'm, before I let you guys start the questions, I'm just going to tell you the three central insights I had during my study of this, and I didn't learn this right away. But the first one I've already mentioned, and that's the updated Golden Rule. And that is, those are the gold make the rules, right? That's, and the second is, science is being used to obscure the truth. Okay. So if you don't understand it ROI, that doesn't mean you're a dummy. What that means is somebody is BSE, you know, because you're just as smart.   As a storyteller, you're smart as the average physician. And sometimes, if you learn too much detail, that actually obscures the truth, because you don't need to be an academic to judge ethics. The last thing is, and this is the important one, if there's controversy about something, that doesn't mean that there's controversy, that means that it doesn't freaking work. Right? If if there's controversy, confusion, or contradictory evidence, don't fall into the trap of believing reasonable people disagree? Because you know, and I know, they've studied hundreds, if not 1000s of patients to produce the controversy. So forget about it, it doesn't work.   So you read a study that says, we don't know for sure they got these barely statistically significant figures or something like that, it means it doesn't work. So that's a good rule of thumb. I mean, I can't state that absolutely. Blanket fashion. But it, it is a good place to start. So ask me anything you want, I can develop the medical specialties or the insurance industry or, you know, a lot of other areas where we've essentially   Roy Barker  07:31 gone off the rails and say, Man, I got a I got a flat. But let's start out with your first concept. The, you know, the golden rule the people with the money, Mike the rule, because there's not only a lot of influence between the the pharmaceuticals and the doctors, that I would suspect with lobbyists and everything else, there's a lot with our lawmakers as well.   Dr. Robert  07:54 Yeah, the lobby for healthcare is far bigger than oil and gas and banking combined is, is monstrous. pharma has a $1.3 trillion gross worldwide, and it's something is well over half the profits occur in the United States and 40% of the sales, it might be 70 or 80% of the profits. So these guys have money to burn.   Roy Barker  08:19 One of the things that just just now thought of this when we were when you were doing your intro is is there a way to track the if I'm a drug maker cannot track the the doctors that are prescribing as though   Dr. Robert  08:33 they track a track exactly who it is. And I here's how they do it. They go to the pharmacy and they get the prescriber number, and then they go to the AMA, and the AMA sells them. The doctors name that associates with a prescriber number the AMA is a very economic organization. They shouldn't be doing this in my opinion. Yeah.   Roy Barker  08:55 Yeah. Because it's good to   Terry  08:56 know I was gonna say it's backlinks, it's like SEO, you know, computerized everything. It's all I don't even know where I was going with that, because I have so many things running through my head, I can't even form a good one.   Dr. Robert  09:12 Let me give you a stunning example of how money pollutes I mean this, this one is going to be hard for you guys to believe. But oncology is one of the most heavily influenced or, you know, cancer therapy. The cancer doctors is one of the most heavily influenced specialties and the reason is, well over half of their incomes come from retailing cancer drugs, they get about 25% and the average cancer drug costs $100,000 a year.   So these guys have these chairs, right the cancer chemotherapy chairs, the more chairs they have and the more patients they have, the more they can bill and they clip 25% off the top of the drugs price. Now you think this is terrible, but it's gets worse. It gets worse. This would be If a doctor sold them the drug, so another doctor, the drug, it would be called camping. It's a federal crime, they put both of them in jail. But the drug companies are allowed to do this because of some sort of exception. Now it gets even worse, they are rewarded, they are rewarded by the milligram. In other words, larger doses make more money for them. So they are incentivized to prescribe very high doses of whatever the most expensive thing is.   Now, I mean, doctors have integrity, we're trained to have ethics in a way that no other industry is. And you know, we're pretty good bunch. But I just want to say that there's no way anyone can get around a financial incentive, even a small one. And these guys well over half of their income, on average comes from far from sales of these drugs that they deliver in the office. Some of the other specialties, like the guys doing the testosterone blockers like Lupron to the best of my knowledge, they get, you know, the shot costs $10,000 or whatever the heck it is, takes two minutes. The doctor gets 25% It's crazy. I mean, it's absolutely crazy.   And that one that was a whole nother story. And that's it's a very damaging drug of questionable utility. According to Otis Brawley, who is the head of the American Cancer Society. Until recently, he thinks that it does more harm than good on average, because the drug actually, you know, the, the prostate cancer is cut by the fatalities are cut by a third, by using that drug. It sounds great, right? But the drug causes so many problems, the overall fatalities probably go up. I mean, it's just crazy. And you know, it's kind of not joke jokingly, but not jokingly, we listen to, especially during the evening news when we listen to these commercials, and they come out with the drug that helps you with this.   And then they've got 10 minutes worth of countries in the world ROI that allow that, yeah, that's direct to consumer advertising. It's an outrage, it got slowly slanted into our system over a period of five to 10 years, when they finally figured out there were no direct laws against it. And it's a complicated political battle, but they these pharmaceutical companies, is very effective is very effective, even though you're not sure what the hell it is, when they're talking about it on the TV. Ask your doctor, and then they go in and ask the doctors and the doctors are so busy. What are they going to do a lot of times they just write for the drug? Yeah,   Roy Barker  12:30 yeah. Well, nothing I was gonna say is they have like 10 minutes worth of but the side effects that this may cause, I mean, in some of the side effects that they list, it's like, wow, I would rather have whatever they're trying to treat is not near as harmful as all these potential side effects that they have. It's crazy. The studies are frequently   Dr. Robert  12:51 obscure the side effects and they measure, they, they measure, they're looking under the money tree, and not the tree of truth. You know what I mean? So, Ben Goldacre wrote a book about the frauds involved in pharmaceutical and device studies. And there are there are, I mean, you cannot imagine what these guys do.   They they mess with the statistics, they conceal studies that don't. Right, and they cherry pick their results in various ways. They change people and put them in the wrong group. So it looks like there are fewer fatalities. I mean, the HPV vaccine, you've heard of that it's a vaccine for venereal warts that supposedly affects cervical cancer. Well, they conceal 50% of the studies. And in my view, the best commentators at Cochrane you know, the Cochrane Institute in Europe, which does meta analyses, they don't think it works, you know, and at least the most sophisticated ones don't think it works. I mean, it's there.   They're influenced by pharma money also. So Japan abandoned the use of HPV, or at least they said it didn't work to their populace, and their inoculation rate dropped to 1% in one year. So that's the truth. They've got a public health system at least as robust as ours. And they they don't use HPV vaccine in any consequential fashion. The rest of the world still on it, pretty much. Yeah.   Terry  14:26 I was gonna ask, so what's the role? No, this is open up a can I was asked, What's the role of the FDA and all of this?   Dr. Robert  14:34 Okay. So the, the FDA, I have a chapter in butchered by healthcare about the FDA and the FDA is the most effective regulatory agent see in the world, but unfortunately, they are since 2003. A law was signed into effect that we could no longer negotiate prices with these. These pharma companies and Since then they've they've just bought everything and the prices have gone way up. But the the the FDA is fed or their revenues come from what's called user fees that the pharmaceutical companies pay them and well over half of their some some sources say 75% or more of their total budget of $5 billion is it comes from directly from pharma.   So they regard pharmaceutical companies as clients, rather than or entities to be regulated because if they refuse a drug, sometimes they can't make their own payroll. Now, you got to realize the the size of these entities they have to regulate, they have $5 billion, which sounds like a lot of money. But pharma is 1.3 trillion worldwide, 40% in the US, and the FDA doesn't have a prayer of watching all these factories in India and China. Inside the US, they inspect them once a year. And they you know, they do a little better job.   But in China, they all these there are the all these stories about these FDA inspectors getting fed fake facilities and fake paperwork and room. It Catherine even wrote a book called bottle of lies, if you're interested in the FDA and, and all that stuff. It's very illuminating. And it really gives you the feeling that the generics, we were I think were 90% generics because we've been so we've been so overpriced by the patent drugs, the patent drugs are good quality, they're actually what they are. They're manufactured under strict controls, but they're so expensive.   And they these guys have decided the price point of making them outrageous is the best strategy. And I guess it is they don't have to do as much and they sell all these things like, like bottled gold. And so we are buying 90% of our medications from India and China's about half and half. And these the generics often are adulterated with some in bad ingredient or they don't work as well. The long lasting generics physicians have often discovered that the long lasting generics are only they only last 12 hours instead of 36 hours.   Cleveland Clinic It was so bad at Cleveland Clinic that they developed their own mini FDA and they started testing their own medications. And they they found out what worked and what didn't. In Africa and other third world less advantaged countries that don't even have an FDA. The physicians keep a small stock of the good drug, the actual patent drug to use on people who are dying, that were the other drug doesn't seem to be working. And so they have to experiment with their patients. But the FDA is a mess. I have insiders quotes from whistleblowers and so on and so forth. But, I mean, it's the best any country has it's better than the one in Europe, you know, or who are who are respected.   Roy Barker  18:02 You know, also anyway. Yeah, unless it's a, you know, on the other show that we have, we've talked a little bit about the new release of the   Terry  18:12 Doom, Doom, that new Alzheimer's drug.   Dr. Robert  18:15 Oh, yeah, that's an outrage. Okay, so the there are about 10 of these patent Alzheimers drugs, and they cost probably a couple $1,000 a month. At a minimum, you know, they're very expensive. It might might only be $1,000 a month, what a bargain. But even the people who work with those drugs and you read their papers, they can't claim they freakin work. I mean, they, they have some small effects. But like the rest of these drug studies, they're basically half fake and half concealed.   And they use contract research groups, and out of the country, and if these guys don't produce the results that they want, they never use them again, you know, so. So anyway, so Alzheimers is a special case. This is very interesting subject because it's Alzheimer's is arguably the most expensive if long term care costs are included is the most expensive disease of all, but we've got excellent, we have an excellent thing to prevent Alzheimer's, right. So in my second book, on hormones, I showed how Astra dial prevents 50 to 80% of all Alzheimers, I mean this could save billions of dollars if it was used and not concealed right and not not derided basically.   Roy Barker  19:42 Yeah, well, this. I'll let Terry's speak a little more to it because she she's done the research but this new adullam it's $56,000 a year. But what they thought mine can't be what what they need, though, They found out two years from now. They found out that the committee that was assigned to assign it what our scientists study it, when they went ahead and said, okay, it's okay for sale. I think 10 of the 11 doctors that were on the panel all resigned because they had already it's it's not   Terry  20:22 it was a it was a an 11 member panels, three of them resigned. And their their vote, the voting on it was there. 10 of them said no, don't release it. And then one was uncertain. And then the FDA went ahead and said, Okay, well, they manipulate it seems like to me, they manipulated the study process, or, you know, the results that they got, and and made it   Roy Barker  20:48 and Okay, and then now I think there's an investigation. Yes, a lot. This   Dr. Robert  20:52 is a, this is a story you'll see over and over and over. And I've got stories like that all through my book, The tragedy of this whole thing, as you guys are finding out, you if you have a chronic disease, and Roy has a problem here. I mean, I think your problems simple compared to someone with cancer, but and you know, the the, the variety of you anyway, so but the tragedy is that you almost need physician level expertise to decipher what the heck to do next, and ever you need and you've got you got your woman by your side there who can help? Yeah,   Roy Barker  21:28 yeah. Well, and that's the thing to, you know, kind of get back to more general terms is, I guess what I see are concerned about is, instead of doctors taking the time to find out what is this underlying issue, they would rather prescribe to treat a symptom instead of actually having a conversation.   Terry  21:46 That's where they get their money is if they like give them the pharmacy, you know, give them the meds,   Dr. Robert  21:53 you know, they are trapped in a in a system that where they're their actions are dictated and even these guys who work for Health Maintenance Organizations, they if they don't have prescribing habits that mimic the, quote, standard of care, which is largely dictated by Big Pharma, influenced by the standards panels, who are paid each one of the persons on the panel has huge conflict of interest paid by two or three pharma companies, for example, antidepressants and statin drugs, right?   Both of those are should be thinly used, and they're the damn no depressants must be 10% of the whole country is on antidepressants, like drugs is 15% or more. But the influence is so the industry influence is so heavy, that your primary care doctor is not an independent actor anymore. He's got an individual license, he's responsible, but he operates under protocols. So they're not they're there.   They're not innocent, but they're not the they're not the real problem. The problem is they're in a matrix, you know, they're a matrix of control. And the money is so huge, that these companies are getting more overt or obvious about their influence. Now, in the last year, they all sort of came out of the closet and said, do as we tell you, or else you know, that's my opinion about what happened.   Roy Barker  23:20 Wow, yeah, it's unbelievable. Yeah, I was just gonna go down I was looking at the second one is the science is obscured, to hide the truth. And so I just was going to ask, you know, in your opinion, are, are these clinical trials large enough? Are they lengthy enough to actually you know, and the problem with anything is that something may be something may be doesn't come to light in the short term, but after you do it for 10 1520 years, all of a sudden, now, there's a big problem. But, again, in your opinion, are we even taking enough time to evaluate these drugs before we release them?   Dr. Robert  24:04 Okay, so Roy, you're asking the right questions, and you're trying, you guys are trying to Paul your way through this mess of data, and try to figure out what the heck is going on. But if you want to read about these clinical trials and the frauds I think the easiest and most approachable book is been gold acres, bad pharma, and that's 10 years old. But the answer is that the answer is that you can hardly trust anything.   Now the doctors are. We are conditioned to think that double blind placebo controlled trials are the beyond handle, but it's a garbage in garbage out situation and Geico situation. And it depends on the intentions of the people who are doing the trial. And so the answer is now, anecdotal medicine is almost better than the clinical trials and I it's almost a waste of time to look at them. Because if you go to the back of the paper and they're sponsored by the the company selling the drug, he was a gold makes the rules right. So they I mean, it's a it's a tragedy but everyone thinks they mean something. One of my friends says the whole thing has been almost garbage since 2000 is not crazy.   I because the the industry is just taking control of freakin everything now. So I don't say this stuff casually. I studied it for four years, I've got 500 References In this book, nothing I say. Everything I say is derivative of authors that have come before me. I didn't do original research. I I read the stuff that was available. And I looked at the references, you know?   Terry  25:52 Oh, my gosh. Shocking, isn't it dairy. It's shocking. And you don't take anything.   Dr. Robert  25:59 You don't want to take anything you want to you basically. And I think you guys are on the right track with your, your keto and your your controlled fasting and your prolonged fasting. I think all that stuff, there is better evidence than anything else we have. I think that the you know, all the fat stuffs turned around want to eat animal fat and all that all those narratives about about the animal fat is being bad for you.   That's all wrong. I mean, it's and it's all that's all food industry driven. And as you may recall the Food and Drug it the FDA is food and drug, right? So they spend half their money half that billion $5 billion, regulating the food industry, and they don't do a very good job there. And I've got references if you're interested in that, if you're interested in the vegan stuff. I have references for that, too.   Roy Barker  26:45 Okay, yeah, I mean, that that is because we are you know, we haven't gone total vegan, we are more what we call plant based. And, you know, we we do not, we eat protein, but not it's not the focal point of the meal. Like it used to be used to you had the, you know, the big meat and a side thing of potatoes or whatever. So, you know, we've tried to flip that. But, you know, it gets back to this this thing about I have read some research, this is not my my research, but I've read a number of studies that say, you know, kind of staying with Alzheimer's is that that can be traced back to the low fat diet of the 70s and 80s. Because we need this fat for our brain to keep those receptors lubricated. And, yeah,   Dr. Robert  27:31 I thought that was interesting. I listened to you. interview someone who'd given cook it on the world for three months to someone and they freakin improved, you know, so who knows? That's that's another anecdote. I have no expertise about this.   Roy Barker  27:46 Yeah, that was a very, it was a very, it was a one person, but it sparked some huge longitudinal studies on that just to, you know, see if this fat intake. But yeah, there's been a lot of saying that that's what has caused this huge spike right now is what we did. And I guess that's kind of our mission to it's changed a lot on this show. But you know, part of it is, you know, I'll speak for me, I'm going into an older phone into the older age brackets sooner than I would like to. And so I need to be sharing carry good health good habits into this. I mean, you can't wait to you're 18 years old and say, Wow, I need to change some things. I mean, yeah.   Dr. Robert  28:30 Well, another clue about my other book, which is the hormone book is after reviewing all the data for hormones, it's my opinion, and brace yourself. It's my opinion, that hormone supplementation over 40 or 50 years old is more important than exercise. Possibly as important as diet, you get it. So there's a lot of there's a lot of data on that a lot of a lot of studies and the standards that are promulgated are a pack of lies, you know, it's crazy. I mean, then we've got, we've got black box warnings on testosterone, estrogen and progesterone. Those three are vital, and they they can save your life and likely make you live longer. They save your alertness decrease Alzheimer's, I mean it has they have multiple good effects. Anyway,   Terry  29:23 is that why is that? I mean, do you do you think that is one of the reasons that all timers and dementia has increased, so   Dr. Robert  29:32 no doubt about it. There's no doubt about it. And the hormone levels are dropping, sperm counts are dropping, and we have good measurements in men about these trends over the last 20 years. We don't know why. It may be stress, it might be chemicals, it might be who knows it might be nutritional, and it might be something else but they it for any given age. Those are dropping and it's if we supplement we can prevent many, many problems.   Roy Barker  30:00 So I'm sure that this is difficult to prove collusion. But do you think that there's a link in not releasing certain products because we would rather sell the drugs on? Instead of being proactive? We'd rather wait and sell the drugs on the back end.   Dr. Robert  30:18 Yeah, you, you have to realize that these companies, they're not evil, and they're not good. They're only interested in money. And so they're willing, they're willing to, there are speculations that they, they would or do sell things that absolutely don't work in order to make the money and they can, they can fake the studies. In other words, you do 20 studies, and one of them is statistically significant, you know, when you that's the only one you publish. So, you know, I mean, they can sell wheat grass and a pill for God knows what.   But it's, it's it's truly a sad story, because some of the things are injurious. There's a class of antidepressants or anti psychotics, because it called atypical antipsychotics. These things are well documented to shorten your life by 10 to 20 years, through diabetes and all this other stuff. However, they're getting passed out like jelly beans to people who have simple depressions. The SSRI drugs like Prozac, they cause consequential violence and suicide in a small number. And those guys are passed out very casually, they're exceedingly addictive.   And, you know, it's it's basically an outrage. And the whole, the whole thing has been covered up since the start, the initial studies for Prozac showed the suicide rate, and that they paid off plaintiff after plaintiff for these things, rather than have it brought out. So, I mean, there's a lot of drugs that are just that are no good. And in fact, the whole psychiatric formulary. And I'm not, I'm not one of those, what do they call it the anti psychiatry is religion. What is that called? The Scientologists are not a Scientologist right?   The but the Scientologists got this one, right. The psychiatry is drugs are the way they're used. Currently, that means indiscriminately on almost everyone, with these standards that were essentially fabricated with hand in glove with the pharmaceutical companies. It's it's an outrage, and that's the most, that's the most expensive medical specialty. And that that whole thing is a mess. I mean, it's truly a mess. And there are a lot of psychiatry is the only specially that has a massive number of people who are essentially psychiatry deniers, they don't think they should be operating at all.   Every other specialty, they're doing something, you know, they're, they're making some mistakes, but psychiatry, the drugs have never been subjected to proper double blind placebo controlled trials. I mean, essentially, if you can't find any, you can't find anybody to put on a sugar pill these days, because we've got 15% of the country taking these darn drugs. Yeah,   Terry  33:08 it's crazy. Yeah. Which leads to which probably has led up to a lot of the violence that's happening, you know, all these I like to see it.   Dr. Robert  33:18 Yeah. The mass violence. Yeah. Everyone knows seems to be associated with with a psychiatric drug use. But of course, everybody's on the damn drugs. So   Terry  33:27 who knows? How do you know? Yeah, yeah.   Roy Barker  33:30 Well, you mentioned something, too, about settlements. And I, I just have mixed emotions about that. Because I feel like if, if I'm able, if I'm a $1.3 trillion industry, I'm able to offer some pretty big dollars for you to not take this to court. You know, it's like, okay,   Dr. Robert  33:50 it's this important point, right. The pharma industry, in terms of their settlements to federal prosecutors, is the most criminal industry in history. They have billions of dollars in settlements every year. It's an unbelievable scene. And essentially, they are paying everyone off to leave them alone and let them continue doing what they're doing. So I mean, it's, it's   Terry  34:16 about it, what and to shut up about it not saying well, you know,   Dr. Robert  34:20 they, when when they make a settlement, they don't admit wrongdoing. But when you give someone $2 billion to to to stop the prosecution, I mean, it's a rich pay off, and the prosecutors can stand on the pile of loot and say they've been, they've saved the world from, you know, one of these companies, and, I mean, it's crazy. Pfizer has profit margins of 40% for the last five years.   So if you know anything about industry, a 10% profit margin is a very good profit margin. It's in a competitive industry, but this is in an industry where the money falls out of the sky on healthcare, and and Pfizer Pfizer for what Have a reason, you know, which we won't speculate about. But you can speculate privately about their profit margins are very high. It's crazy.   Terry  35:08 And so what? How does that? So you mentioned Pfizer, so how does that tie into the COVID? vaccination? Maybe? Okay,   Dr. Robert  35:18 so, here now, I just want to make a comment about doctors and politics, right? So if you go to a doctor, and he talks politics to you, that's called a boundary violation. It's not considered cool in medical ethics, ethics term, just like, just like in polite company, we don't talk about religion, politics or net worth, right? It's not it's not considered reasonable. So this vaccine has been kicked around so much. It's being censored by YouTube and all these crazy media people. So I think we can consider the vaccine a political issue.   So I'm going to make a comment which will tip you off to what I think about these modern vaccines without specifically commenting on the COVID varieties. Right. So we have we have the the two vaccines that were have been promulgated in the last 20 years now, you know, measles vaccine, and all that was before that, and they all have robust effectiveness, right. But the two are the flu vaccine. And HPV, I already told you what I thought of HPV vaccine, Japan rejected it.   And they've got a very good public health service that seems less influenced by pharma. But for the flu vaccine, this costs billions and billions of dollars every year, Britain and France stockpile this thing. And their governments are influenced by the manufacturers, obviously, because that stuff doesn't work very well at all, it doesn't do much of anything. It may decrease the length of the the severity of the disease by eight hours or some crazy thing.   And this is not a controversial thing. You can go to Cochrane Reviews, you just Google Cochrane Reviews flu vaccine, you can read the summaries of the last few meta analyses and they, you know, read between the lines, but it does it doesn't say the freakin stuff works, you know, it doesn't work very well, it's very expensive. So we can, we can certainly extrapolate pharmas products, which we know a lot about the other products, I mean, these these site drugs, they've tracked the rise in disability very closely.   So that is a suggestion that the drugs cause the rise and disability, right? These there's a lot of other drugs like the stat that basically, I mean, there is arguable small use cases for it, but they've, they've gone so crazy, we've got 8060 or 80 million people in the US on status. And they are toxic, they can cause an occasional fatality and muscle wasting a lot of stuff like that. So the only two use cases for that one is hereditary hypercholesterolemia, which means you have a super high cholesterol and post heart attack. If you're not in those two groups, you're better off doing Roy's method of fasting or being careful with your ketone, you know, or intermittent fast.   Roy Barker  38:18 So what about Black Label or black? I can't remember, I think that's it, like off off label uses. Like, we designed this medicine for this because I hear that both ways. I hear there are some medicines out there that help other things they won't let them do. But then I also hear that there are some medicines for one thing that they're using for others that cause harm as well.   Dr. Robert  38:42 Something between a third and two thirds of drugs are prescribed off label. So it's completely conventional to do that. The thing that's not conventional is for Big Pharma to advertise there. patented medication for every freakin use under the sun. And there's many, many examples of this in my book, and that's what they get the fines for. That's all this left on the books to get these guys. I mean, research fraud, they sometimes identify some of that, but it's largely done outside of the country. Those studies are accepted, analyzed inside the country.   And I mean, that doesn't seem to do much. You know, they put an occasional doctor in jail for a couple of years for that, but they're, they're obvious their champion, their champion fraudsters, you know, but it's done universally. I mean, again, that Goldacre book is a good source. And I'll mention Whitaker's book about the psychiatrists in the psychiatry he uses. He's a seminal author about that, where he dislikes the data and shows that there. I mean, arguably, those drugs are if they work is for a very narrow group.   Roy Barker  39:52 Is there any studies on on that at all? Do they have to do any research on the off label? Or do they go on go through a whole new clinical trial for those?   Dr. Robert  40:01 Well, that's the thing they're on, you know, I mean, I suppose you see a clinical trials are done to create a patent, which is a monopoly for whatever it is 20 years, you know, from the very start of it. And that's the profitable stuff. When a drug passes off patent, other companies apply to produce it, right. And then in theory, it becomes a matter of supply and demand and whether this stuff really works.   Right. But it's not that clear, because there are all kinds of lawsuits that fall that go back and forth between these these big groups, the patent drug manufacturers, and the generic drug manufacturers, and, and sometimes they're just paid. The generic drug manufacturers are just paid not to produce the drug. I mean, it goes on and on.   I described that in butchered by healthcare. But Did that answer your question? Yeah, yeah, yeah. And so. So there are many good uses, there are many good uses for off label prescribing. And in fact, ineligible for physician does that. And I think that there are many, many treatments that are not recognized because they can't be patented. And among these are bioidentical hormones, because pieces of the human body cannot be patented.   In theory, they've got some loopholes, like they patent certain doses of these darn things, which doesn't make any sense to me so. So you go through what's called a compounding pharmacy, which is 5% or less of the total pharmacists, and they are allowed to make a drug only for one person, they can't mass produce the drug. So, and there, there are other constraints on those guys, too, that I   Roy Barker  41:46 yeah. So let's talk for a minute about, there's so many drugs prescribed about polypharmacy. And I know that some in theory are, if we use the same pharmacy, they should catch that, but I'm going to tell you that we use a national brand and have had some that slipped through like nobody's even taken a look at that.   Dr. Robert  42:11 So drug interactions are not studied when the drug is patented. In other words, only one drug at a time is, is studying, right? So we know, we know something about drug interactions from after market effects, and maybe studies that have been done on it. But in the modern nursing home, it's not uncommon to see patients on 20 drugs. And these include that a typical anti psychotic that shortens their lifestyle life lifespan, because it shuts them up.   I mean, they've got to control them somehow, I guess. But 20 medications is a medication farm and not a patient, they are just farming the revenues. And you can imagine these things, the expense of them and the insurance reimbursement and the insanity of the whole thing is just a, it's just a travesty. There are people who are studying this that I cited in butchered by healthcare, and they there are specialties that revolve around trying to take people off of as many of their medications as possible.   So if you're a patient and you're not sick, I would advise you just to be very careful about what you take. Because the indications for conditions that you can't feel like blood pressure have been trumped up. In other words, the standard for when you Medicaid for blood pressure, there was very little scientific evidence that medicating past the upper limit 160 or the systolic blood pressure that trying to get it lower than that there's very little evidence that it makes any difference.   And there's certainly almost no evidence that medicating past 140 systolic makes any difference. And so, especially if you're a senior, that they that, you know, there's there's it's ridiculous, but but the standards have been changed progressively for cholesterol for blood pressure for other medical conditions that are medicated prophylactically. And it prophylactically means before you get sick. So I mean, it's crazy.   The whole thing about the bone density drugs. I mean, that's a that's a crazy story. And these things are very toxic. And they create problems have their own, like fractures and certain long bones like the femur, they create rotty jaw bones, right. And in theory, they densify the bones as well. They are a net loss in my opinion, after reading all about it. I mean, it's it's a crazy crazy thing, and you get those things and they last years inside your body, and they're a shot administered in the office. So the doctor gets 25% of the gross revenue. I mean, it's just it's it's a conflict of interest. Nobody You can get around.   Roy Barker  45:01 Well, some of what led to that, too was, you know, in, in the nursing home expecially was, you know, when physical restraints, you know, people started taking a hard look at that, and they outlawed them. It's unfortunate, but, you know, we call it chemical restraints, all they did was just moved from having them, you know, tied down in the chair with the belt to chemical chemical restraint of the medication that they give them.   Dr. Robert  45:29 So I don't know what there's a good solution for that. But let me just draw a similar point in the insanity field in this psychotic field, right? Well, almost all psychiatric conditions. And these are defined as things for which there is no laboratory test. So the psychiatrists are going almost purely by their gut instinct and talking right, unlike any other medical field, but oh, let's see, I lost my thread. What was I talking about?   Right now we're talking about the chemic, chemical restraints, right? Okay. So, in psychiatry, every single psychiatric entity, like schizophrenia, like anxiety, like depression, waxes and wanes, it goes up, it goes down, goes up and goes down, right? But when we start people on psychiatric medications, it habituates them to the medication, and produces chronicity. So this has increased, or it's thought to have increased the number of people on social security disability, all this crazy stuff. So anyway, that's an that's, I don't have an answer for people who are completely out of it, you know, and letting them go through their thing in a walk facility, and then letting them out when they're when they're doing okay, that might be the way to go.   It's not inexpensive, but the drugs are not inexpensive either. Well, and the bad thing about the some of the, you know, worst cases in the nursing home, especially was it really wasn't about the patient acting out, it was just if you could medicate enough of them, you didn't have to spend time, you know, devote time and resources to them. Unfortunately, it takes a lot of expertise to carefully medicate these people. And you have to have someone who cares about often about people who are demented, you know, and it's, it's hard, hardly anybody. It takes kind of a safe saintly person to be interested in keeping these people clean and in the best possible condition.   And there are private places that do a good job, but the usual nursing home, Medicaid is heavily. I mean, it's crazy. The pharmacies who supply these nursing homes, make millions and millions of dollars per nursing home. I mean, it's crazy. It's like, they turn out blister packs for every patient in the nursing home, often 20 medications, I mean, in the hundreds of dollars a month at a minimum for the for the moderately priced ones, and just break it in, you know, and the nurses pass them out. And go ahead.   Terry  48:07 I was I was just gonna say I mean, that's. So what do we do back in the olden days, When, when, when Big Pharma wasn't in control? I mean, we they did, they did send people with senility and, and psychiatric issues, they did put them away for a while or a lifetime. But there weren't many of them, because they weren't taking the drugs to be able to cause whatever it is, they're   Dr. Robert  48:31 right, we've got a control group for psychiatry, and that's called the third world, right. And they don't have the money to spend on these drugs. So Whittaker and other Robert Whittaker, and other people have looked at that. And they get better results than we do. Our drugs encouraged chronicity and dependency in the third world, they'd lock them up for a while, maybe give them a few drugs, but they don't give them the drugs and definitely the way the way our standards have developed to, to do this, you know, depression, that you know, this chemical, chemical fault in the brain that's supposed to be depression that the SSRI antidepressants are supposed to fix. You've heard about that.   Right? It's a chemical deficiency in the brain. Well, that was made up, that idea was made up by a marketer. That was not there's no science behind that at all. We don't know what the hell's happening in the brain is made up by a marketer. So that thing took hold. And once a bell is wrong, it cannot be unrung. So everybody in the country thinks that the depressed people have a chemical deficiency in the brain. And that means that you have to take the drug forever and pay the pharma company forever. And, you know, I mean, it all falls right, made up by a marketer at Smith Kline and French.   Roy Barker  49:48 So what about allergies have has this overmedication or maybe it's the food source or whatever that it's, you know, we had a casual conversation about this the other day That, you know, as I was growing up, and I'm not, you know, mostly back in the 60s and 70s It's been a while, but it didn't seem to be kids with the chronic asthma, the chronic allergies, peanut butter, you know, things like that. And it seemed like nowadays there are so much   Terry  50:19 more. All right, yeah, they're all they can't have dairy, they can't they're an app have everything gluten free, no peanuts, all of that.   Dr. Robert  50:28 I don't have any specific knowledge about that, except for it sounds to me, like it's part of the diagnosis creep, that has been fostered by industry and abetted by the doctors, you know, just like for the blood pressure, the cholesterol, you know, the the bone density, the bone density story is a is a six story that started in some, you know, medical meeting where they got together and they all decided that bone density below a certain amount was going to be called osteopenia, which is not true osteoporosis.   But then they decided that osteo Pina peenya, had to be medicated with these toxic drugs to prophylactic or prevent osteoporosis, which that's the link was never proven. But now we've got, we got all these people on these drugs, they're getting less popular because their toxicities are more widely known. And who wants to have a patient who has a necrosis or a rotten jaw, you know, I mean, that's, but I guess if you're getting paid 20 $500 for a shot, you know, maybe you're risking, you know, you get a you get a herd of about 40 of men, they're coming in once a month, or whatever it is, you got a lot of money on your hands.   Terry  51:41 So what's a patient to do? That's the hard part. Okay, what do you do?   Dr. Robert  51:47 Right? Well, my wife has a chronic problem. And I be I become her advocate. And it's taken my background to keep her out of trouble. And she's doing very well. But I think that you guys, you guys don't have serious problems yourself. I think you can research what you're doing. You stay away from those drugs, Metformin is okay, but the rest of them are not good. And they'll keep you from losing weight. But if you have a complicated problem, you can go to the best doctors in the country virtually now. And Trump put out this executive order. And I don't think Biden is countermanded. That said that virtual consultations, even on the first visit, are cool, you get it. Whereas before, they would always insist that you come to the office to see them to see you. Because it was considered beneath the standard of care to see a patient virtually or on the phone, especially for the first visit, there's something to that an experienced physician can just look at somebody and they can see physical signs, they can see, they can see stuff they can't see as well over zoom.   Although these are very clear images, it's not as good. You know, they get you get your clothes off and look even without even listen to your lungs or looking, you know, just kind of look them over. And and they get hints to what's going on. And they can lead to good ideas about therapy and diagnosis. But you can go to Stanford, and you can do a virtual consultation with these people. And if they won't allow a first time virtual consultation, fly out there, pay for the whole thing, and then do the subsequent visits, and then get your local doctor to do whatever the other guy tells him to do. So you can get the best care in the country, anywhere you live.   You know, if you've got a few dollars to rub together, I mean, it's not free. But it's not so outrageously expensive that that you can't get it done. The Second. Second thing is, you know, the problem with healthcare is twofold. Right? Have I want to do too much those are the people on fee for service and fever services, enormous conflict of interest, right? It's impossible to get away from I mean, I was a cosmetic surgeon, I got paid for doing breast dogs. I wanted to do them, you know, and I would like to think I never oversold it on someone that had breasts that were big already or something but you know, you got to make the customers happy, right?   But the problem is for fee for service, they want to do too much but the other guys the HMO guys, they're on salary, and they're often incentivized in various subtle ways to do less. So you got to watch those guys and make sure that you're getting the best care from them. They have all the modern stuff. They can do whatever they want, but it often takes a supervising physician outside the system. If you have a complicated problem. If you're have cancer, cancer is there is many different diseases. It's complicated.   Many different specialties are required to manage it frequently. You get a cardiologist involved and you know the cancer doctor and he you know, I mean it just goes on and on and on. And there's many possible And the thing is an art, which doesn't work very well, if it's applied the way the standards go, two months of improved survival is what 95% plus of the cancers get from our chemotherapy. And that's not that's not controversial. Two months survival improvement, right? We can cure about five to seven of these cancers. If we catch them at the right stage. It really I mean, you know, what, testicular cancer, some lymphomas, leukemias, you know, some other some other entities get cured, which is, you know, that's a blessing.   But the rest of it is, it's definitely an art. And if you establish good relationships with the people, if you don't, if you don't think that they're relating to you, personally, you need to go elsewhere. I mean, doctors are human beings too. And if they seem like they're pushing patients through the clinic, and that's what they're up to. You can sense it your your judgment is better than you think. And you go on and study everything you can, if you have friends that are nurses, or doctors who can help advocate for you and learn everything they can, they'll they possibly will be more sophisticated, although sometimes they are just part of the freakin machine.   Roy Barker  56:11 So we're running way long. But I did want to ask you, you wrote another book about hormones. And so we just wanted to touch on that briefly. I know you talked a little bit about testosterone and estrogen earlier, but now kind of what's going on over in that realm? Well,   Dr. Robert  56:28 the interesting thing is, the amazing thing is that every single hormone has been run down by standards groups, right? The FDA has, there's a thing called a blackbox warning the FDA puts on drugs, that it deems it's a postmarket thing, right? They put on rather than send the drug back to the manufacturer, which would, you know, it's very expensive. And in theory, the drug works, they put a warning on the drug.   So theoretically, patients and physicians can be careful about it and not, not, you know, be aware that there there are risks, and they put black box warnings, unwarranted blackbox warnings on testosterone, estrogen and progesterone based on obsoletes drug studies. In other words, the drugs studies were done is called the Women's Health Initiative, which you probably heard of that thing evaluated drugs that shouldn't be used any longer for chronic care.   Okay, like Premarin, Premarin is horse urine, estrogen. Now that stuff has its place. But for chronic care, it has some low level risks, that true estrogen that's Astra dial, which is the compound that should be used is bioidentical doesn't have, right. And, you know, there's a whole series of caveats. But But basically, in testosterone, it's practically unbelievable what's happened with testosterone, they put a blackbox warning on testosterone based on two studies, or they look through the wrong end of the telescope. In other words, they took people on testosterone and look for problems.   So that's the wrong way to evaluate a drug. What you need to do is take 1000 people or whatever half up on the drug half, I'm off the drug and see what happens to them in the future. Right. So testosterone, they've stuck this blackbox warning on testosterone for stroke and heart disease, when this stuff has enormously beneficial effects on weight loss. It's the best weight loss drug we've ever had. It's much better than phentermine.   It has many positive effects. And you guys, you know, are of the age group where you should consider this stuff and you read my book and see what you think I've got referral sources in there. And even a drug as harmless as progesterone, which is the other female hormone. There's a story they started about that was you don't need anyway.   Terry  58:56 So it's it's a crazy I was put, I was given a cream.   Dr. Robert  59:00 I mean, the cream is the cream for progesterone is ineffective. It doesn't give you enough to drop like,   Terry  59:07 I quit. I mean, I didn't take it very well.   Dr. Robert  59:09 You should take oral micronized progesterone, and the doses and everything are in my hormone secrets book. Okay. So that's something that the women should study any woman over 50 should be intimately familiar with all that material. Because you're not going to get it your it's going to be hard to get from anywhere anywhere else. I mean, you can if you go to the right doctor, they can help but there's there's a lot of quote, controversy and the the subjects been just completely covered up. Sorry, Roy.   Roy Barker  59:40 Oh, no, no, no, I just I was thinking you might actually thought of something back kind of on the drug issue is that you know, we talked about how things kind of go around with the FDA looking down over this but I'm able to walk into any drugstore, any grocery store And by any form of some kind of a supplement, and they don't have a my understanding with them is they have little to no oversight except for the company. So most of them come from China to do like, okay, yeah. Oh, yeah, I guess the for briefly on that, you know the benefits versus the pitfalls of you know, walking in and, and one for me that I know as that I was told about was iron like, for most men, too much iron can be dangerous more dangerous than than low iron.   Dr. Robert  1:00:36 Don't take iron, don't take iron, right? But yeah, Terry if you don't have menstrual periods you shouldn't need iron to see. But the reason why you have low iron in the blood blood is you have blood loss, either through mineral or if you have a GI bleed a slow gut bleed, you can get a lower iron. And if you have that you want to check it out. You don't want to just take iron.   Roy Barker  1:00:57 Yeah, yeah, no, no, I wasn't taking it, I have a colon cancer. That was just an example of, you know, one that I know for certain that I've heard is detrimental to men. But then, you know, like some of the others I've heard that they can have interactions with, you know, certain medications that we're taking. So just you know, it kind of the more I've learned about the supplements, kind of the scarier that whole thing is, and the   Terry  1:01:21 fish and fish oil Didn't we just learned about fish? Well, we cut out the fish oil supplements, because we spoke to a neural neurologist, who told us that how it was processed, processes that out of what you need. So to go and get, you know, they have to, they have to cook it at such high heat that it actually makes it detrimental. But you can take there's a liquid three, six and nine, that's a lot more.   Roy Barker  1:01:48 It's more efficient. But it's also like it has all the nutrients that you really need. So little things like that, you know, like the Who would think you know, nobody ever talked to me about this whole thing with fish oil, everybody's like official is good, but it's the process that kills it.   Dr. Robert  1:02:04 I'm not an expert on fish oil I but I understand it's out. The thing I do know about is vitamin D, which actually is not a vitamin, it's a hormone. And you can get your levels drawn of D, your primary care can do that. Or you can go straight through life ext

In this Halloween themed season four premiere episode, JL hosts with Taylor-Taylor as she sits in for Nikki B to discuss current topics, present a new IMQ, and feature funny segments. JL will give his point-of-view in his address, and Taylor-Taylor will bring you entertainment news

Part One of the podcast we have a lively discussion about menopause and the benefits of hormone supplemenation. We dive into the differences between the types of HRT and the benefits. We also begin our discussion on thyroid.Amazon Affiliate Link Highly recommended Liquid Thyroid Supplement Amazon Affiliate Link Robert Yoho - Hormone Secrets Book Website Stop the thyroid madness Learn more about Robert Yoho at his websiteRoberty Yoho retired MD, Author 2020-2021 full-time writer.​2019: retired from my medical and surgical practice and resigned my medical license. I had a fantastic career, and I was initially sad to end it. But I was soon relieved that I was no longer responsible for patient care and was able to write full time without conflicts of interest. See also the first chapter of Butchered by Healthcare for the circumstances, included on this website under "Writing."1992-2019: Cosmetic surgery practice, Pasadena, Visalia, and Oxnard, California. Liposuction, breast implantation specializing in through the umbilicus (belly button), laser blepharoplasty, face-lifts, facial implants, laser resurfacing, vein treatments, hair transplantation. Operated medical hyperbaric chamber between 1996 and 2000.1987-1994: General practice in Pasadena, California.1984-1987: Employed by the Huntington Memorial Hospital Emergency Medicine Group,SPECIAL EXPERTISEOne of the most extensive experiences in the United States with tumescent liposuction and Brazilian butt lift with fat. Some of our liposuction supply vendors say we are their largest account internationally for several years.Trans-umbilical breast augmentation is a surgery that many try, but few become proficient. Thousands performed.One of only two surgeons in the United States who passed the specialty boards in both cosmetic surgery and emergency medicine.PAST MEMBERSHIPS IN PROFESSIONAL SOCIETIESLos Angeles County Medical SocietyCalifornia Medical AssociationAmerican Society of Cosmetic Breast SurgeryFellow, American Academy of Cosmetic SurgeryACADEMIC STAFF APPOINTMENTS (INACTIVE)​Drew-King Medical Center, assistant clinical professor, Department of Dermatology. Training residents in cosmetic surgery techniques.BOARD CERTIFICATION EXAMINATIONS TAKEN AND PASSED (NOW INACTIVE):American Board of Emergency Medicine (ABEM), 1987. Re-certification examination passed l999 and 2009. 3000 CoolidgeRd., East Lansing, Michigan 48823-6319American Board of Dermatologic Cosmetic Surgery passed in 1999. Recertification passed ten years later. 18525 Torrence Ave., Lansing Illinois 60438. (708) 474-7200.American Board Laser Surgery passed in 2000.417 Palmtree Dr. Bradenton, Florida 34210-3009.ACLS re-certification 1999, 2002, 2005. ATLS in past.Member, Fellow, and Past President, American Society of Cosmetic Breast Surgery: testing included written and oral examination as well as peer observation of surgical technique.PEER REVIEW WORKProduced with Robert Goldweber, M.D., Socrates Emergency Medicine Oral Boards Review Course, 1987. This was distributed nationwide for over 5 years.Emergency Medicine Residency Director Huntington Memorial Hospital (coordinated and trained Los Angeles County Hospital emergency medicine residents) 1985-1987.Board of Directors of California Academy of Cosmetic Surgery, 1998-2000.Outpatient surgical facilities reviewer training for IMQ surgical centers and AAAHC surgical centers. (Inactive)Testified before California Medical Board 6/01 regarding liposuction standards and 11/02 regarding expert witness problems.

Part One of the podcast we have a lively discussion about menopause and the benefits of hormone supplemenation. We dive into the differences between the types of HRT and the benefits. We also begin our discussion on thyroid. Amazon Affiliate Link Highly recommended Liquid Thyroid Supplement  Amazon Affiliate Link Robert Yoho - Hormone Secrets Book  Website Stop the thyroid madness  Learn more about Robert Yoho at his website Roberty Yoho retired MD, Author  2020-2021 full-time writer. ​2019: retired from my medical and surgical practice and resigned my medical license. I had a fantastic career, and I was initially sad to end it. But I was soon relieved that I was no longer responsible for patient care and was able to write full time without conflicts of interest. See also the first chapter of Butchered by Healthcare for the circumstances, included on this website under "Writing." 1992-2019: Cosmetic surgery practice, Pasadena, Visalia, and Oxnard, California. Liposuction, breast implantation specializing in through the umbilicus (belly button), laser blepharoplasty, face-lifts, facial implants, laser resurfacing, vein treatments, hair transplantation. Operated medical hyperbaric chamber between 1996 and 2000. 1987-1994: General practice in Pasadena, California. 1984-1987: Employed by the Huntington Memorial Hospital Emergency Medicine Group, SPECIAL EXPERTISE One of the most extensive experiences in the United States with tumescent liposuction and Brazilian butt lift with fat. Some of our liposuction supply vendors say we are their largest account internationally for several years. Trans-umbilical breast augmentation is a surgery that many try, but few become proficient. Thousands performed. One of only two surgeons in the United States who passed the specialty boards in both cosmetic surgery and emergency medicine. PAST MEMBERSHIPS IN PROFESSIONAL SOCIETIES Los Angeles County Medical SocietyCalifornia Medical AssociationAmerican Society of Cosmetic Breast SurgeryFellow, American Academy of Cosmetic Surgery ACADEMIC STAFF APPOINTMENTS (INACTIVE) ​Drew-King Medical Center, assistant clinical professor, Department of Dermatology. Training residents in cosmetic surgery techniques. BOARD CERTIFICATION EXAMINATIONS TAKEN AND PASSED (NOW INACTIVE): American Board of Emergency Medicine (ABEM), 1987. Re-certification examination passed l999 and 2009. 3000 CoolidgeRd., East Lansing, Michigan 48823-6319 American Board of Dermatologic Cosmetic Surgery passed in 1999. Recertification passed ten years later. 18525 Torrence Ave., Lansing Illinois 60438. (708) 474-7200. American Board Laser Surgery passed in 2000.417 Palmtree Dr. Bradenton, Florida 34210-3009. ACLS re-certification 1999, 2002, 2005. ATLS in past. Member, Fellow, and Past President, American Society of Cosmetic Breast Surgery: testing included written and oral examination as well as peer observation of surgical technique. PEER REVIEW WORK Produced with Robert Goldweber, M.D., Socrates Emergency Medicine Oral Boards Review Course, 1987. This was distributed nationwide for over 5 years. Emergency Medicine Residency Director Huntington Memorial Hospital (coordinated and trained Los Angeles County Hospital emergency medicine residents) 1985-1987. Board of Directors of California Academy of Cosmetic Surgery, 1998-2000. Outpatient surgical facilities reviewer training for IMQ surgical centers and AAAHC surgical centers. (Inactive) Testified before California Medical Board 6/01 regarding liposuction standards and 11/02 regarding expert witness problems.

In episode ten, JL and Nikki B play some "games", present a new IMQ, and feature funny segments. JL will give his point-of-view in his address, and Taylor-Taylor will bring you entertainment news.

In episode nine, JL and Nikki B discuss current topics, present a new IMQ, and feature funny segments. JL will give his point-of-view in his address, and Taylor-Taylor will bring you entertainment news.

In episode eight, JL and Nikki B discuss current topics, present a new IMQ, and feature funny segments. JL will give his point-of-view in his address, and Taylor-Taylor will bring you entertainment news.

In episode seven, JL and Nikki B discuss current topics, present a new IMQ, and feature funny segments. JL will give his point-of-view in his address, and Taylor-Taylor will bring you entertainment news.

In episode six, JL and Nikki B discuss current topics, present a new IMQ, and feature funny segments. JL will give his point-of-view in his address, and Taylor-Taylor will bring you entertainment news. JL will also make a big, special announcement!

In episode five, JL and Nikki B discuss current topics, present a new IMQ, and feature funny segments. JL will give his point-of-view in his address, and Taylor-Taylor will bring you entertainment news.

In episode four, JL and Nikki B discuss current topics, present a new IMQ, and feature funny segments. JL will give his point-of-view in his address, and Taylor-Taylor will bring you entertainment news.

In episode three, JL and Nikki B discuss current topics, present a new IMQ, and feature funny segments. JL will give his point-of-view in his address, and Taylor-Taylor will bring you entertainment news.

In episode two, JL and Nikki B discuss current topics, present a new IMQ, and feature funny segments. JL will give his point-of-view in his address, and Taylor-Taylor will bring you entertainment news.

Nominate Dynamic Duel DC vs. Marvel for the BEST FANS award in the Colorado Podcast Awards! https://www.houseofpod.org/the-hoppysCheck out a preview of our card game Dynamic Duel WAR here: https://www.youtube.com/watch?v=r08y22b-iMQ and become a patron of ours here: https://www.patreon.com/dynamicduelListen to the Blast From Our Past Podcast: https://podcasts.apple.com/us/podcast/the-blast-from-our-past-podcast/id1268418694**SPOILER REVIEW**• 0:00:00 - Introduction • 0:04:02 - No-Prize Time • 0:07:40 - WB releasing Wonder Woman 1984 in theaters and HBO Max this Christmas • 0:10:32 - Molyneux Sisters hired to write Deadpool 3 for the Marvel Studios • 0:13:02 - Question of the Week • 0:13:35 - Batman: Soul of the Dragon trailer • 0:16:16 - Batman: The Movie Review • 1:07:30 - Sign offiTunes: https://podcasts.apple.com/us/podcast/dynamic-duel-dc-vs-marvel/id1076213902Spotify: https://open.spotify.com/show/2OPFg1DRSzHvWlbkYG5l0S Facebook: https://facebook.com/DynamicDuelPodcast/Twitter: https://twitter.com/Dynamic_DuelInstagram: https://instagram.com/dynamicduelpodcastPatreon: https://patreon.com/dynamicduelMerch: https://tee.pub/lic/dynamicduelExecutive producers: John Speas, Jace Crump, Ken Johnson, Isaiah Bethune, Zachary Hepburn, John Starosky and John BechininaClash Defiant, Take a Chance by Kevin MacLeod (incompetech.com) Licensed under Creative Commons: By Attribution 3.0 License creativecommons.org/licenses/by/3.0/#Batman #BatmanAndRobin #DCComics

El director del laboratorio IMQ de Erandio, Mikel Longa, ha explicado que el incremento de pruebas PCR en la sanidad privada no ha supuesto un aumento en el beneficio de los laboratorios privados....

También la Universidad de Deusto ha iniciando en su FabLab -su laboratorio de fabricación digital- la elaboración de material sanitario para hacer frente al Covid-19. Desde viseras protectoras, a “mangos anti virus” para abrir puertas, cajas para proteger a los sanitarios en la intubación de pacientes con coronavirus o codos, conectores y adaptadores para respiradores. Entre algunas de las entidades con las que el centro académico ya está en contacto se encuentran el IMQ, Covideuskadi u OpenSpace de Zorrozaurre. Los detalles los hemos conocido en Onda Vasca Grupo Noticias con Szilard Kados director del Deusto FabLab. Este mismo martes han puesto a punto los nuevos pedidos para el Hospital Gregorio Marañón, el Instituto Oncológico de Donostia y el Grupo IMQ en Euskadi.

También la Universidad de Deusto ha iniciando en su FabLab -su laboratorio de fabricación digital- la elaboración de material sanitario para hacer frente al Covid-19. Desde viseras protectoras, a “mangos anti virus” para abrir puertas, cajas para proteger a los sanitarios en la intubación de pacientes con coronavirus o codos, conectores y adaptadores para respiradores. Entre algunas de las entidades con las que el centro académico ya está en contacto se encuentran el IMQ, Covideuskadi u OpenSpace de Zorrozaurre. Los detalles los hemos conocido en Onda Vasca Grupo Noticias con Szilard Kados director del Deusto FabLab. Este mismo martes han puesto a punto los nuevos pedidos para el Hospital Gregorio Marañón, el Instituto Oncológico de Donostia y el Grupo IMQ en Euskadi.

Deusto Business Alumni celebra un Deustalks en Donosti, bajo la línea de apoyo e impulso de los jóvenes directivos. Un evento patrocinado por el IMQ. En esta ocasión, contamos con la participación de Oscar Vicente, director general España de Bolton Food. En la jornada ofrecerá una ponencia bajo el título: Marketing en la era del Consumidor Activista: las marcas como motores auténticos del cambio. Donald Trump, Brexit, fake news, cambio climático, desigualdad, fin de la clase media, inseguridad, epidemias, privacidad, #MeToo… El mundo tal y como lo conocíamos está cambiando radicalmente. La gente está expresando más que nunca su frustración con el status quo y desconfían de forma masiva de instituciones, medios, empresas e incluso ONGs… y también de las marcas. El consumidor, cada vez más informado y consciente, ya no solo participa en política con el voto, sino también con el consumo, y es a través de sus compras que asume un nuevo poder. En esta era de desconfianza y ultra-información, las marcas tienen la oportunidad de volver a importar. En un futuro cercano, los consumidores sólo comprarán marcas que tengan un impacto positivo auténtico en la sociedad. Compartiremos algunos ejemplos locales e internacionales que marcan el camino.

On this Very Important and information-packed Episode of the ASC Podcast with John Goehle we update you on some major news items in the ASC Industry including the Wind Down of IMQ a California Based Accrediting Organization, Recent changes to the Conditions for Coverage that affect ASCs, including a major change to CRNA Oversight, and a discussion of how you should be preparing a plan for the next year and an interview with Bob Zaza about starting up new program. Visit the ASC Podcast with John Goehle Website Benefits of Becoming a Patron Member Support the ASC Podcast with John Goehle by becoming a patron member. Get AEU Credits for Listening to the Podcast! Purchase John’s Books Go to the ASC Podcast Store

Did you know -- NAU was named an Emerging Hispanic Serving Institution by the U.S. Department of Education? Here at our Flagstaff campus, Latino students comprise 21 percent of our total enrollment. Our NAU-Yuma location which was designated as a Hispanic Serving Institution in 2007, enrolls 71 percent Latino students. Between September 15 and October 15, we will be observing Hispanic Heritage Month and celebrating the contributions of both Hispanic and LatinX Americans. From the sounds of mariachi to campus events honoring our diversity, we're taking you inside NAU to find out what LatinX heritage month means to our students, faculty and staff.First up, we hear from the President and Vice President of NAU's LatinX Student Union who share with us who they looked up to growing up, the lessons their parents imprinted on them, what folklorico figure gives them chills and what NAU's LSU wants you to know. Special thanks to NAU Mariachi Mar y Sol for the music you heard this episode, Emily and Vanessa from NAU's LatinX Student Union, Destinee King, our Inclusion Coordinator in IMQ and all those who shared why celebrating LatinX heritage month is important to them: Bekka, Jose, Leslie, Margarita, Marcela, Ruby and Dani.

Show #408.   Can You Help Me Fight The Fossils? Read More About Patreon here EVne.ws/patreon   Read today’s show notes on https://www.evnewsdaily.com   Good morning, good afternoon and good evening wherever you are in the world, welcome to EV News Daily for Thursday 7th March 2019. It’s Martyn Lee here and I’ve been through every EV story I could find today, and picked out the best ones to save you time.   Thank you to MYEV.com for helping make this show, they’ve built the first marketplace specifically for Electric Vehicles. It’s a totally free marketplace that simplifies the buying and selling process, and help you learn about EVs along the way too.   Formula E on terrestrial free TV this weekend, Hong Kong race to be screened live by BBC2.   CARLOS GHOSN RELEASED ON BAIL "An an unusual move in Japan, former Nissan chairman Carlos Ghosn was released on bail Wednesday after 108 days in jail, according to a report in Automotive News." Says Green Car Reports: "Ghosn, who is known as the father of the Nissan Leaf for his work championing the car's production, was arrested in November on charges of allegedly misusing company funds and underreporting his compensation for 10 years.In Japan, criminal suspects are routinely held without bail, and prosecutors can file new charges against jailed suspects to extend their detention, as they had with Ghosn."   “I am innocent and totally committed to vigorously defending myself in a fair trial against these meritless and unsubstantiated accusations,” he said in a statement following his release.   https://www.greencarreports.com/news/1121916_japanese-judge-releases-former-nissan-chairman-ghosn-on-bail     SUPERCHARGER V3 CHARGES AT 1000 MILES PER HOUR V3 is a completely new architecture for Supercharging. A new 1MW power cabinet with a similar design to our utility-scale products supports peak rates of up to 250kW per car. At this rate, a Model 3 Long Range operating at peak efficiency can recover up to 75 miles of charge in 5 minutes and charge at rates of up to 1,000 miles per hour. Combined with other improvements we’re announcing today, V3 Supercharging will ultimately cut the amount of time customers spend charging by an average of 50%, as modeled on our fleet data.Supercharger stations with V3’s new power electronics are designed to enable any owner to charge at the full power their battery can take – no more splitting power with a vehicle in the stall next to you. With these significant technical improvements, we anticipate the typical charging time at a V3 Supercharger will drop to around 15 minutes.   On-Route Battery Warmup New Supercharging infrastructure isn’t the only way we are improving our customers’ charging experience. Beginning this week, Tesla is rolling out a new feature called On-Route Battery Warmup. Now, whenever you navigate to a Supercharger station, your vehicle will intelligently heat the battery to ensure you arrive at the optimal temperature to charge, reducing average charge times for owners by 25%.   This combination of higher peak power with V3, dedicated vehicle power allocation across Supercharger sites, and On-Route Battery Warmup enables customers to charge in half the time and Tesla to serve more than twice the number of customers per hour. Additionally, we are also unlocking 145kW charge rates for our 12,000+ V2 Superchargers over the coming weeks. By increasing the number of vehicles we’re able to charge at each Supercharger in a day, the investment we’re making in our network will go significantly further with every V3 station deployed. Paired with other savings, these efficiencies will translate to an increased pace of investment for Superchargers moving forward, with a continued focus on getting to 100% ownership coverage across all regions we operate.   We will increase Model S and X charging speeds via software updates in the coming months. V3 Supercharging will roll out to the wider fleet in an over the air firmware update to all owners in Q2 as more V3 Superchargers come online. Our first non-beta V3 Supercharger site will break ground next month, with North American sites ramping in Q2 and Q3 before coming to Europe and Asia-Pacific in Q4.   So we need to see all of this in the context of the Model Y, the Semi Truck and the Roadster.     PORSCHE TAYCAN DEBUT AND LAUNCH INFORMATION UNVEILED? “We may finally have some much-anticipated information about the Porsche Taycan reveal and deliveries.” “Porsche’s first all-electric car is coming, and many people are extremely excited about its potential. So much so, that orders are already sold out for at least the first year. Reports say that Porsche plans to build about 40,000 cars initially, however, it seems they’re all spoken for at this point. Hybrid Cars were apprised of some information on the Taycan EV Forum. The site came across a tweet from a user whose Porsche rep leaked some new details about the upcoming performance EV’s timeline.”   “It claims that the Taycan will be unveiled this coming September, with deliveries starting in January 2020. As Hybrid Cars points out, the Frankfurt Motor Show is in September, so this might be the case.”   Per my Porsche rep, Porsche has closed down its Deposit program for the US due to high demand, Sep 2019 unveil confirmed, 1mo prior to unveil build out for orders to open up, Jan 2020 deliveries   Dennis C. (@ClarkDennisM)   https://insideevs.com/porsche-taycan-debut-launch-information/amp/     KIA BRINGS E-SOUL TO EUROPE, UPGRADES NIRO HYBRID AND PHEV Kia used the Geneva International Motor Show as the platform to introduce the battery-electric e-Soul to Europe, as well as to reveal new upgrades to the Niro Hybrid and Plug-in Hybrid. Every Kia vehicle on show in Geneva employs the brand’s mild-hybrid, hybrid, plug-in hybrid, or electric vehicle technology. The e-Soul makes its European debut with a choice of two electric powertrains. Now in its third generation, the Kia e-Soul’s new-generation battery packs—either 64 kWh or 39.2 kWh in capacity—are up to 30% more energy efficient than Europe’s current best-selling electric vehicle. The car is offered in Europe without the option of an internal combustion engine. The new e-Soul goes on-sale in select European markets from the end of the first quarter of 2019, sold as standard with Kia’s 7-year, 150,000-kilometer warranty, which also covers the car’s electric motor and battery pack.   ALL-NEW PEUGEOT E-208 LOOKS DYNAMIC IN GENEVA "The all-new Peugeot 208 with the all-electric e-208 version shown in Geneva in GT trim, raised a lot of interest. The new French subcompact brings to the table completely new dynamic styling." says Mark Kane for InsideEVs: "In the current specification – especially with the 50 kWh battery,  WLTP range of 340 km (211 miles) and 100 kW electric motor – it could be the tamer of the Renault ZOE, but there is one doubt. In several months, ZOE will get major upgrade in the form of a second generation version, which should make both cars at least competitive. Orders will be accepted from late summer 2019 on, while the launch is expected in the fall of 2019."   https://insideevs.com/peugeot-e-208-debut-geneva-photos-videos/amp/   CURRENT BMW I3 TO GET REVAMP RATHER THAN ALL-NEW MODEL “The BMW i3 is entering its seventh year of production, but the electric car will continue to be produced with further updates planned. The BMW i3 will last beyond the usual seven-year model cycle and get further updates, according to the boss of BMW i Division." Reports John McIlroy for AutoExpress: "The electric city car recently received its second battery upgrade, taking the capacity to 120Ah (42.2kWh) and the real-world range to around 160 miles. However, speaking to Auto Express at the recent Geneva Motor Show, i Division chief Robert Irlinger said the latest battery tweaks would not be the last upgrades in the i3’s life - and stressed that the car is not bound by conventional life cycles."   https://www.autoexpress.co.uk/bmw/i3/106240/current-bmw-i3-to-get-revamp-rather-than-all-new-model   NISSAN TO INTRODUCE E-POWER MODELS IN EUROPE Nissan unveiled the IMQ concept crossover, equipped with its award-winning e-POWER system, and announced it will launch the electrified powertrain technology in Europe. The technology will debut in European markets by 2022, Roel de Vries, Nissan corporate vice president, said at the Geneva International Motor Show. e-POWER has been a hit with consumers in Japan, where it’s helped make the Nissan Note the country’s best-selling registered car. Combining 100% electric motor drive with a gasoline engine that charges the battery, e-POWER cars give customers instant, smooth acceleration and excellent fuel efficiency. Introducing the technology in Europe will reinforce Nissan’s leadership in electrified vehicles in the region, where the Nissan LEAF is already the best-selling electric car. Building on the success of LEAF, e-POWER will be among a suite of new technologies coming to Nissan’s best-selling vehicles in Europe in the coming three years. By 2022 sales of electrified Nissan vehicles will increase five-fold, and by the end of that year will be double the market average.       COMMUNITY And thanks to MYEV.com they’ve set us another Question Of The Week. Keep your comments coming in on email and YouTube…   How do you feel about Tesla’s move to online-only sales? Do you want to test drive a car first? What about if you have to arrange finance to buy it, even tho Tesla say you can return it?     I want to say a heartfelt thank you to the 197 patrons of this podcast whose generosity means I get to keep making this show, which aims to entertain and inform thousands of listeners every day about a brighter future. By no means do you have to check out Patreon but if it’s something you’ve been thinking about, by all means look at patreon.com/evnewsdaily     PHIL ROBERTS / ELECTRIC FUTURE (PREMIUM PARTNER) ELECTRICMOTORING.NET (PREMIUM PARTNER) BRAD CROSBY (PREMIUM PARTNER)   DAVID ALLEN (PARTNER) OEM AUDIO OF NEW ZEALAND AND EVPOWER.CO.NZ (PARTNER) SASCHA PALLENBERG (PARTNER) JON BEARDY MCBEARDFACE / KENT EVs (PARTNER) PAUL O’CONNER (PARTNER) ALAN ROBSON (EXECUTIVE PRODUCER) ALEX BANAHENE (EXECUTIVE PRODUCER) ALEXANDER FRANK @ https://www.youtube.com/c/alexsuniverse42 ARILD GEIR SKAALSVEEN (EXECUTIVE PRODUCER) ASHLEY HILL (EXECUTIVE PRODUCER) BÅRD FJUKSTAD (EXECUTIVE PRODUCER) BARRY PENISTON (EXECUTIVE PRODUCER) BOB MUIR / GINGERCOMPUTERS.COM IN DUNDEE (EXECUTIVE PRODUCER) BORISLAV BORISOV (EXECUTIVE PRODUCER) BRENT KINGSFORD (EXECUTIVE PRODUCER) BRIAN THOMPSON (EXECUTIVE PRODUCER) BRIAN WEATHERALL (EXECUTIVE PRODUCER) BRYAN YOUNG / CONFT.SHOW PODCAST (EXECUTIVE PRODUCER) CESAR TRUJILLO (EXECUTIVE PRODUCER) CHRIS BENSON (EXECUTIVE PRODUCER) CHRIS HOPKINS (EXECUTIVE PRODUCER) CRAIG COLES (EXECUTIVE PRODUCER) CRAIG ROGERS (EXECUTIVE PRODUCER) DAMIEN DAVIS (EXECUTIVE PRODUCER) DARREN BYRD (EXECUTIVE PRODUCER) DARREN SANT (EXECUTIVE PRODUCER) DAVE DEWSON (EXECUTIVE PRODUCER) DAVID BARKMAN (EXECUTIVE PRODUCER) DAVID FINCH (EXECUTIVE PRODUCER) DAVID PARTINGTON (EXECUTIVE PRODUCER) DAVID PRESCOTT (EXECUTIVE PRODUCER) DIRK RUTSATZ (EXECUTIVE PRODUCER) DON MCALLISTER / SCREENCASTSONLINE.COM (EXECUTIVE PRODUCER) ENRICO STEPHAN-SCHILOW (EXECUTIVE PRODUCER) FREDRIK ROVIK (EXECUTIVE PRODUCER) GEORGE CLARGO (EXECUTIVE PRODUCER) JACK OAKLEY (EXECUTIVE PRODUCER) JAMES STORR (EXECUTIVE PRODUCER) JASON FAN (EXECUTIVE PRODUCER) JEFF ERBES (EXECUTIVE PRODUCER) JERRY ALLISON (EXECUTIVE PRODUCER) JOHN BAILEY (EXECUTIVE PRODUCER) JON KNODEL (EXECUTIVE PRODUCER) JON TIMMIS (EXECUTIVE PRODUCER) JUAN GONZALEZ (EXECUTIVE PRODUCER) KEN MORRIS (EXECUTIVE PRODUCER) KEVIN MEYERSON (EXECUTIVE PRODUCER) LARS DAHLAGER (EXECUTIVE PRODUCER) LAURENCE D ALLEN (EXECUTIVE PRODUCER) LESZEK GRZYL (EXECUTIVE PRODUCER) LOUIS HOPKIN (EXECUTIVE PRODUCER) LUKE CULLEY (EXECUTIVE PRODUCER) MARCEL LOHMANN (EXECUTIVE PRODUCER) MARCEL WARD (EXECUTIVE PRODUCER) MARTIN CROFT (EXECUTIVE PRODUCER) MATT PISCIONE (EXECUTIVE PRODUCER) MATTHEW ELLIS (EXECUTIVE PRODUCER) MATTHEW GROOBY (EXECUTIVE PRODUCER) MAZ SHAR (EXECUTIVE PRODUCER) MICHAEL PASTRONE (EXECUTIVE PRODUCER) MIKE ROGERS (EXECUTIVE PRODUCER) MIKE WINTER (EXECUTIVE PRODUCER) NEIL E ROBERTS FROM SUSSEX EVS (EXECUTIVE PRODUCER) PAUL SEAGER-SMITH (EXECUTIVE PRODUCER) PAUL STEPHENSON (EXECUTIVE PRODUCER) PETE GLASS (EXECUTIVE PRODUCER)  PHIL MOUCHET (EXECUTIVE PRODUCER) PHILIPPE CALVE (EXECUTIVE PRODUCER) RAJ BADWAL (EXECUTIVE PRODUCER) RAJEEV NARAYAN (EXECUTIVE PRODUCER) RENÉ SCHNEIDER (EXECUTIVE PRODUCER) ROD JAMES (EXECUTIVE PRODUCER) RUPERT MITCHELL (EXECUTIVE PRODUCER) SARAH MCCANN (EXECUTIVE PRODUCER) SCOTT CALLAHAN (EXECUTIVE PRODUCER) SEIKI PAYNE (EXECUTIVE PRODUCER) STEVE JOHN (EXECUTIVE PRODUCER) STUART HANNAH (EXECUTIVE PRODUCER) THE LIMOUSINE LINE SYDNEY (EXECUTIVE PRODUCER) WALTER MACVANE (EXECUTIVE PRODUCER) ZACK HURST (EXECUTIVE PRODUCER)     You can listen to all 407 previous episodes of this this for free, where you get your podcasts from, plus the blog https://www.evnewsdaily.com/ – remember to subscribe, which means you don’t have to think about downloading the show each day, plus you get it first and free and automatically. It would mean a lot if you could take 2mins to leave a quick review on whichever platform you download the podcast. And if you have an Amazon Echo, download our Alexa Skill, search for EV News Daily and add it as a flash briefing. Come and say hi on Facebook, LinkedIn or Twitter just search EV News Daily, have a wonderful day, I’ll catch you tomorrow and remember…there’s no such thing as a self-charging hybrid.   CONNECT WITH ME! EVne.ws/itunes EVne.ws/tunein EVne.ws/googleplay EVne.ws/stitcher EVne.ws/youtube EVne.ws/iheart EVne.ws/blog EVne.ws/patreon   Check out MYEV.com for more details:

- Carlos Ghosn Granted Bail, But It's Appealed - GM to Stop Production in Ohio Plant - Hyundai and Kia Rolling Out Digital Keys - Ford Transit Van Updated - Lamborghini Aventador SVJ Roadster - New Mercedes-AMG GT R Roadster - EQV is Mercedes' Electric Van Concept - Volkswagen I.D. BUGGY Concept - Alfa Romeo Tonale PHEV Concept - Kia Imagines a New EV Concept - Nissan IMQ Signals Next-Gen CUV - Subaru VIZIV Adrenaline Concept

- Carlos Ghosn Granted Bail, But It's Appealed- GM to Stop Production in Ohio Plant- Hyundai and Kia Rolling Out Digital Keys- Ford Transit Van Updated- Lamborghini Aventador SVJ Roadster- New Mercedes-AMG GT R Roadster- EQV is Mercedes' Electric Van Concept- Volkswagen I.D. BUGGY Concept- Alfa Romeo Tonale PHEV Concept- Kia Imagines a New EV Concept- Nissan IMQ Signals Next-Gen CUV- Subaru VIZIV Adrenaline Concept

In this episode of the ASC Podcast with John Goehle check in on the latest news in the ASC Industry, review some recent experiences with facilities facing deemed status surveys, review credentialing basics, discuss accreditation and deemed status surveys and the benefits of accreditation, and interview the executive director of one of the newer national accreditation organizations, IMQ.

Ana Sánchez, dermatóloga de IMQ, nos ha explicado en Euskadi Hoy Magazine todo lo que debemos saber sobre la prevención del cáncer de piel.

Ana Sánchez, dermatóloga de IMQ, nos ha explicado en Euskadi Hoy Magazine todo lo que debemos saber sobre la prevención del cáncer de piel.

1.-)Nuevo audio en el que os hablo del triunfo del fin de semana ante Tecnyconta Zaragoza. 2.-)La situación de la ACB con la noticia aparecida en el diario el País. 3.-)La presentación del patrocinador IMQ por esta temporada y una más. La próxima más. Un saludo a todos.

Entrevista con el Jefe de los Servicios de Urgencias de IMQ, Fidel Fuentes, sobre el bulo viral que se está transmitiendo a través del whatsapp, que dice cómo hay que reaccionar ante un ataque al corazón, dando instrucciones inutiles ante esta circunstancia.

Entrevista con el Jefe de los Servicios de Urgencias de IMQ, Fidel Fuentes, sobre el bulo viral que se está transmitiendo a través del whatsapp, que dice cómo hay que reaccionar ante un ataque al corazón, dando instrucciones inutiles ante esta circunstancia.

Emisión del programa Sin tocar el balón de Uribe FM (www.uribefm.com) los viernes de 18.30 a 20.00, presentado por Tomás Campo junto con Diego González, Benat López, Nacho Ortiz, Endika Martínez e Íñigo Burgos. Iniciamos esta semana el programa con toda la previa del Athletic-Getafe. Un encuentro en el que los leones necesitan una victoria para seguir fortaleciendo esa valiosa posición de Champions que por ahora ocupa el cuadro bilbaíno. Una de las principales novedades en el once va a ser la ausencia de Adúriz sancionado la semana pasa frente al Villarreal. Para cubrir esta variante las dos opciones con las que cuenta Ernesto Valverde serían Gaizka Toquero y el delantero del filial Guillermo Fernández, ante la baja por lesión de Kike Sola, en el que será el regreso a San Mamés del Athletic después de las visitas consecutivas al Valencia y el Villarreal. Por otra parte, nuestros comentaristas nos hacen un amplio repaso al sorteo de los cuartos de final de la Liga de Campeones donde han sucedido los siguientes emparejamientos: Barça-Atlético de Madrid, Real Madrid-Borussia Dortmund, PSG- Chelsea y Manchester United- Bayern de Munich. Y por supuesto nuestros contertulios habituales se han animado a dar su pronóstico sobre estas eliminatorias y también sobre el Real Madrid-Barça de este domingo, un clásico que con permiso del Atlético de Madrid puede determinar bastante quien va a ser el ganador del título liguero de esta temporada 2013-2014. En otro orden de cosas, hemos entrevistado a Jon Salvador para conocer el proyecto deportivo “Maratones Solidarios”. Un proyecto deportivo iniciado junto con el atleta paraolímpico Javier Conde en el que decide afrontar retos solidarios como por ejemplo participar en 28 maratones en ciudades que han sido sede de los Juegos Olímpicos o Paralímpicos para luego donar lo recaudado a asociaciones contra la exclusión social. Semana convulsa en el mundo del basket en Bilbao. Primero porque IMQ ha anunciado la paralización de las negociaciones para el patrocinio del Bilbao Basket después de conocer la situación real del club puesto que no se dan unas condiciones de estabilidad necesarias para afrontar la deuda. En el plano deportivo, el Bilbao Basket necesita buscar un triunfo en casa este domingo frente al Real Madrid para cortar esa mala racha de derrotas consecutivas que provoca que prácticamente no le queden probabilidades de engancharse a los play off. En cuanto a la NBA destacamos la noticia sobre que habrá publicidad en la camisetas de los equipos en lugar de poner solamente el nombre de la ciudad o de la franquicia como está ocurriendo actualmente. Nuestro compañero Endika Martínez nos trae toda la información del ciclismo que pasa principalmente por la victoria de Alberto Contador en la Tirreno-Adriático 2014 que supone su primera victoria en carrera por etapas del corredor de Pinto desde la Vuelta a España 2012. Terminamos resumiendo lo que fue el ajetreado Gran Premio de Australia de Fórmula 1 que hace unos días sirvió para arrancar la temporada 2014 y donde hemos visto que a los equipos se les han atragantado todas las novedades reglamentarias que ha decidido introducir la FIA. En cuanto a este fin de semana, hablamos del arranque de la nueva temporada de Moto GP, del Campeonato de España de Rallys de tierra y del Rally de Hondarribia.